Healthcare costs in the U.S. are skyrocketing, leaving millions of Americans struggling to afford basic medical care. But here’s where it gets controversial: top health insurance executives recently testified before Congress, and their solutions—or lack thereof—have sparked fierce debate. On Thursday, leaders from five of the nation’s largest health insurance companies, including UnitedHealth Group, CVS Health, Elevance Health, the Cigna Group, and Ascendiun, faced lawmakers to address the growing affordability crisis. The hearing, led by Republican representatives Brett Guthrie and Morgan Griffith, was part of a broader effort to curb healthcare costs ahead of the 2026 midterm elections.
In a surprising move, UnitedHealth Group CEO Stephen Hemsley announced that the company would rebate profits from its Affordable Care Act (ACA) plans to customers this year. However, Hemsley was quick to note that UnitedHealth is a relatively minor player in the ACA individual market, raising questions about the impact of this gesture. And this is the part most people miss: while this rebate might seem like a win for consumers, it barely scratches the surface of a much larger issue—the systemic lack of transparency and competition in the healthcare industry.
The hearing comes at a critical time, as healthcare expenses continue to soar. According to a KFF survey, family premiums for employer-based insurance jumped 6% in 2025, averaging nearly $27,000 annually. Overall U.S. healthcare spending surged 7.2% in 2024, topping $5.3 trillion—a staggering 18% of the nation’s GDP. Griffith bluntly stated, ‘The insurance market is dominated by a handful of Fortune 50 corporations that control the majority of the national market. It lacks transparency and is not easily navigable.’
Lawmakers didn’t hold back during the hearing. Representative Diana Harshbarger, a Republican pharmacist, grilled executives on prescription drug coverage decisions and pricing, accusing insurers of dictating market rules rather than fostering competition. ‘That’s not competition, that is control,’ she declared. Meanwhile, Representative Alexandria Ocasio-Cortez highlighted the issue of corporate consolidation, pointing out that companies like CVS Caremark own insurers, pharmacies, and drug manufacturers. ‘The health insurance gets a cut, the pharmacy benefits manager gets a cut, the drug manufacturer gets a cut, and the patient gets screwed,’ she said. Ocasio-Cortez argued that dismantling monopolies is a rare point of agreement between capitalists and democratic socialists.
The political divide on healthcare solutions was also on full display. Democrats are pushing to extend enhanced premium tax credits that lower ACA plan costs, while Donald Trump opposes restoring Obamacare subsidies, instead proposing direct payments to consumers. However, Trump’s plan has faced criticism for its lack of detail and feasibility. Earlier this month, the House passed legislation to re-establish these tax credits, but enrollment in ACA plans has already dropped. Last year, a record 24 million Americans signed up, but this year, enrollment is down to 22.8 million, with both new and returning enrollees declining.
Here’s the burning question: Can rebating profits and extending subsidies truly address the root causes of skyrocketing healthcare costs, or is a more radical overhaul of the system needed? What do you think? Share your thoughts in the comments—let’s spark a conversation that could shape the future of American healthcare.
